Jennifer P. Arbitrario

SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo

Jennifer P. Arbitrario, Brian J. Belmont, Marc Evanchik et al. · Cancer Chemotherapy and Pharmacology · 2009 · 67 citations

Medicine, Oncology, Pharmacology +9

Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo

Caroline D. Scatena, Jeffrey L. Kumer, Jennifer P. Arbitrario et al. · Cancer Chemotherapy and Pharmacology · 2010 · 47 citations · Full text

Medicine, Oncology, Pharmacology +14

Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists

Min Zhong, Shen Wang, Kenneth J. Barr et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9